OLS data system/global survey of lightning

A global lightning climatology is being assembled from the nighttime imagery of the DMSP Optical Linescan Sensor (OLS). Lightning saturates the visible channel of the OLS at nighttime and can be identified as a horizontal streak on the order of 50-100 km in horizontal extent. Lightning streaks apparent in the film strips located at the National Snow and Ice Data Center (NSIDC) prior to 1991 are being digitized. An initial survey was completed for the F7 satellite observation period January 1986 - October 1987 and for the Q satellite for the period June-July 1973. Comparisons between the OLS lightning climatology with the Arkin GPI data set during the 1986-87 El Nino event shows similar regional variations in convective activity. The digital archive of global DMSP data began at the end of February. Software is being developed at both MSFC and NSIDC to extract, navigate, and view the OLS fine and smooth imagery

BCNU for recurrent glioblastoma multiforme: efficacy, toxicity and prognostic factors

<p>Abstract</p> <p>Background</p> <p>The prognosis for patients with recurrent glioblastoma is still poor with a median survival between 3 and 6 months. Reports about the application of carmustine (BCNU), one of the standard chemotherapeutic drugs in the treatment of newly diagnosed glioblastoma, in the recurrent situation are rare.</p> <p>Methods</p> <p>We performed a retrospective analysis of 35 patients with recurrent or progressive glioblastoma treated with 80 mg/m²BCNU on days 1 on 3 intravenously at our department for efficacy, toxicity and prognostic factors. Progression free survival and overall survival were estimated by the Kaplan-Meier method. The influence of age, Karnofsky performance status (KPS), tumor burden, pretreatment with temozolomide (TMZ), type of surgery for initial diagnosis and number of previous relapses on outcome was analyzed in a proportional hazards regression model.</p> <p>Results</p> <p>The median age of the group was 53 years, median KPS was 70. Median progression free survival was 11 weeks (95% confidence interval [CI]: 8-15), median overall survival 22 weeks (95% CI: 18-27). The rate of adverse events, especially hematological toxicity, is relatively high, and in 3 patients treatment had to be terminated due to adverse events (one pulmonary embolism, one pulmonary fibrosis, and one severe bone marrow suppression). No influence of age, KPS, tumor burden, pre-treatment with TMZ and number of previous relapses on outcome could be demonstrated, while gross total resection prior to recurrence showed a borderline statistically significant negative impact on PFS and OS. These data compare well with historical survival figures. However prospective randomized studies are needed to evaluate BCNU efficacy against newer drugs like bevacizumab or the intensified temozolomide regime (one week on/one week off).</p> <p>Conclusion</p> <p>In summary, BCNU treatment appears to be a valuable therapeutic option for recurrent glioblastomas, where no other validated radio- and/or chemotherapy are available.</p

Radiotherapeutic alternatives for previously irradiated recurrent gliomas

Re-irradiation for recurrent gliomas has been discussed controversially in the past. This was mainly due to only marginal palliation while being associated with a high risk for side effects using conventional radiotherapy

Iodine-125 brachytherapy for brain tumours - a review

Iodine-125 brachytherapy has been applied to brain tumours since 1979. Even though the physical and biological characteristics make these implants particularly attractive for minimal invasive treatment, the place for stereotactic brachytherapy is still poorly defined

Global Land Ice Measurements from Space

The NSIDC at the University of Colorado has successfully completed the tasks outlined in its proposal 0999.08.1216B, the 'Global Land Ice Measurements from Space' grant funded by NASA under NAG5-9722. The Global Land Ice Measurements from Space (GLIMS) grant reported on here is one of the first completed elements of the overall GLIMS project that continues with separate funding from NASA, the United States Geological Survey (USGS), and internationally by many national agencies and universities. The primary goals of GLIMS are to survey significant numbers of the world's 160,000 glaciers with data collected by the ASTER (Advanced Spaceborne Thermal Emission and reflection Radiometer) instrument aboard the EOS Terra spacecraft, and Landsat ETM+ (Enhanced Thematic Mapper Plus) and to make these data available to users in a common and easily usable format. GLIMS participants include: NSIDC as developer of the GLIMS database, USGS Flagstaff as the GLIMS Coordination Center, USGS EROS Data Center (EDC) as the archive for satellite imagery used in GLIMS analyses (NASA funding for GLIMS also includes the Flagstaff group and EDC through the related ASTER Science Team and Land Processes Distributed Active Archive Center [LP DAAC] activities), and approximately twenty two Regional Centers (RCs). RCs are funded by the national agencies of participating countries to analyze satellite imagery for a specified set of glaciological parameters and provide the results to NSIDC for archive and distribution to the public

Confining the Concept of Vascular Depression to Late-Onset Depression: A Meta-Analysis of MRI-Defined Hyperintensity Burden in Major Depressive Disorder and Bipolar Disorder

BACKGROUND: The vascular depression hypothesis emphasizes the significance of vascular lesions in late-life depression. At present, no meta-analytic model has investigated whether a difference in hyperintensity burden compared to controls between late-life and late-onset depression is evident. By including a substantial number of studies, focusing on a meaningful outcome measure, and considering several moderating and control variables, the present meta-analysis investigates the severity of hyperintensity burden in major depressive disorder (MDD) and bipolar disorder (BD). A major focus of the present meta-analysis refers to the role of age at illness onset. It is analyzed whether late-onset rather than late-life depression characterizes vascular depression. METHOD: In total, 68 studies were included in the meta-analysis and a multilevel random effects model was calculated using Hedges' g as the effect size measure. RESULTS: The severity of hyperintensity burden was significantly greater in the patient group compared to the control group. This effect was evident regarding the whole patient group (g = 0.229) as well as both depression subgroups, with a significantly greater effect in BD (g = 0.374) compared to MDD (g = 0.189). Hyperintensity burden was more pronounced in late-onset depression than in early-onset depression or late-life depression. A considerable heterogeneity between the included studies was observed, which is reflected by the large variability in effects sizes. CONCLUSION: In conclusion, the present meta-analysis underscores the association of hyperintensities with MDD and BD. Especially late-onset depression is associated with an increased hyperintensity burden, which is in line with the vascular depression hypothesis. The results suggest that it might be more feasible to confine the concept of vascular depression specifically to late-onset depression as opposed to late-life depression. Further research is needed to understand the causal mechanisms that might underlie the relation between hyperintensity burden and depression